APA (7th ed.) Citation

RH, W., DY, J., J, L., LX, X., F, W., QQ, S., & HX, Z. (2025). Development of a Predictive Model for the Risk of Myelosuppression in Patients With Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy. Clinical Medicine Insights. Oncology, 19, 11795549251381678. https://doi.org/10.1177/11795549251381678

Chicago Style (17th ed.) Citation

RH, Wang, Jiang DY, Lu J, Xun LX, Wang F, Shao QQ, and Zhang HX. "Development of a Predictive Model for the Risk of Myelosuppression in Patients With Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy." Clinical Medicine Insights. Oncology 19 (2025): 11795549251381678. https://doi.org/10.1177/11795549251381678.

MLA (9th ed.) Citation

RH, Wang, et al. "Development of a Predictive Model for the Risk of Myelosuppression in Patients With Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy." Clinical Medicine Insights. Oncology, vol. 19, 2025, p. 11795549251381678, https://doi.org/10.1177/11795549251381678.